United States - English - NLM (National Library of Medicine)

eci pharmaceuticals, llc - salsalate (unii: v9mo595c9i) (salsalate - unii:v9mo595c9i) - salsalate 500 mg - carefully consider the potential benefits and risks of salsalate tablets, usp and other treatment options before deciding to use salsalate tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorder. salsalate tablet, usp is contraindicated in patients with known hypersensitivity to salsalate. salsalate tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings – anaphylactoid reactions , and precautions - preexisting asthma ). salsalate tablet, usp is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings ). drug abuse and depende

United States - English - NLM (National Library of Medicine)

andapharm llc - salsalate (unii: v9mo595c9i) (salsalate - unii:v9mo595c9i) - salsalate 500 mg - carefully consider the potential benefits and risks of salsalate tablets, usp and other treatment options before deciding to use salsalate tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, and related rheumatic disorder. salsalate tablet, usp is contraindicated in patients with known hypersensitivity to salsalate. salsalate tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings-anaphylactoid reactions , and precautions-preexisting asthma ). salsalate tablet, usp is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings ). drug abuse and dependence have not been r

United States - English - NLM (National Library of Medicine)

nationwide laboratories, llc - salsalate (unii: v9mo595c9i) (salsalate - unii:v9mo595c9i) - salsalate 500 mg - carefully consider the potential benefits and risks of salsalate tablets, usp and other treatment options before deciding to use salsalate tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorder. salsalate tablet, usp is contraindicated in patients with known hypersensitivity to salsalate. salsalate tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings – anaphylactoid reactions , and precautions - preexisting asthma ). salsalate tablet, usp is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings ). drug abuse and depende

United States - English - NLM (National Library of Medicine)

westminster pharmaceuticals, llc - salsalate (unii: v9mo595c9i) (salsalate - unii:v9mo595c9i) - salsalate 500 mg - carefully consider the potential benefits and risks of salsalate tablets, usp and other treatment options before deciding to use salsalate tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, and related rheumatic disorder. salsalate tablets, usp is contraindicated in patients with known hypersensitivity to salsalate. salsalate tablets, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings - anaphylactoid reactions , and precautions-preexisting asthma ). salsalate tablets, usp is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings ). drug abuse and dependence have not been reported with salsalate.

United States - English - NLM (National Library of Medicine)

marlex pharmaceuticals inc - salsalate (unii: v9mo595c9i) (salsalate - unii:v9mo595c9i) - salsalate 500 mg - carefully consider the potential benefits and risks of salsalate tablets, usp and other treatment options before deciding to use salsalate tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorder. salsalate tablet, usp is contraindicated in patients with known hypersensitivity to salsalate. salsalate tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings - anaphylactoid reactions, and precautions - preexisting asthma). salsalate tablet, usp is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings). drug abuse and dependence

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - salsalate (unii: v9mo595c9i) (salsalate - unii:v9mo595c9i) - salsalate 750 mg - indications and usage carefully consider the potential benefits and risks of salsalate tablets and other treatment options before deciding to use salsalate tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorder. contraindications salsalate tablets is contraindicated in patients with known hypersensitivity to salsalate. salsalate tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings – anaphylactoid reactions , and precautions - preexisting asthma ). salsalate tablets is contraindicated for the treatment of peri-operative pain in the setting of coronary artery b

United States - English - NLM (National Library of Medicine)

carilion materials management - salsalate (unii: v9mo595c9i) (salsalate - unii:v9mo595c9i) - salsalate 750 mg - carefully consider the potential benefits and risks of salsalate tablets, usp and other treatment options before deciding to use salsalate tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see ). salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorder. warnings salsalate tablet, usp is contraindicated in patients with known hypersensitivity to salsalate. salsalate tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see , and ). warnings – anaphylactoid reactions precautions - preexisting asthma salsalate tablet, usp is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graf

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - salsalate (unii: v9mo595c9i) (salsalate - unii:v9mo595c9i) - salsalate 750 mg - carefully consider the potential benefits and risks of salsalate tablets, usp and other treatment options before deciding to use salsalate tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorder. salsalate tablet, usp is contraindicated in patients with known hypersensitivity to salsalate. salsalate tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings - anaphylactoid reactions, and precautions - preexisting asthma). salsalate tablet, usp is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings). drug abuse and dependence

Malta - English - Medicines Authority

espl regulatory consulting ltd - mesalazine - modified-release tablet - mesalazine 1600 milligram(s) - antidiarrheals, intestinal antiinflammatory/antiinfective agents

United States - English - NLM (National Library of Medicine)

franklin pharmaceutical llc - mesalamine (unii: 4q81i59gxc) (mesalamine - unii:4q81i59gxc) - mesalamine 4 g in 60 ml